Memorial Sloan Kettering Cancer Center
ASCO 2022 on the Phase 3 DESTINY-Breast 03 Trial: HER2+ BC Updates
By
Nebraska Oncology Society
FEATURING
Chau Dang
By
Nebraska Oncology Society
FEATURING
Chau Dang
Login to view comments.
Click here to Login